Published 2 hours ago • loading... • Updated 1 hour ago
GSK Shares Slump as Vaccine Sales Decline Despite Revenue Beat
Summary by Business-live.co.uk
7 Articles
7 Articles
+2 Reposted by 2 other sources
GSK sees falling vaccine sales take shine off earnings
The drugs giant revealed vaccine sales fell 2% to £2.6 billion in the three months to September 30 as demand waned for its shingles and RSV jabs.
GSK shares fell to their lowest level in six months following the drugmaker's third-quarter earnings report, as a decline in vaccine sales raised concerns about growth prospects, Bloomberg reports.
Coverage Details
Total News Sources7
Leaning Left2Leaning Right1Center3Last Updated50% Center
Bias Distribution
- 50% of the sources are Center
50% Center
L 33%
C 50%
R 17%
Factuality
To view factuality data please Upgrade to Premium











